UnitedHealth Group Incorporated $UNH is Maple Rock Capital Partners Inc.'s 3rd Largest Position

Key Points

• Maple Rock Capital Partners increased its UnitedHealth stake by 216.2% in the second quarter to 681,100 shares worth approximately $283.1 million, making UNH its third-largest holding and 5.6% of its portfolio.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $456.56; JPMorgan raised its target to $516.
• UnitedHealth exceeded quarterly earnings expectations, reporting $6.38 EPS versus the $4.94 consensus estimate, while declaring a quarterly dividend of $2.32, or $9.28 annually.

Maple Rock Capital Partners Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 216.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 681,100 shares of the healthcare conglomerate's stock after purchasing an additional 465,700 shares during the quarter. UnitedHealth Group makes up 5.6% of Maple Rock Capital Partners Inc.'s investment portfolio, making the stock its 3rd largest holding. Maple Rock Capital Partners Inc. owned about 0.08% of UnitedHealth Group worth $283,086,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Orgel Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at $235,000. JNBA Financial Advisors boosted its holdings in shares of UnitedHealth Group by 1.7% during the 2nd quarter. JNBA Financial Advisors now owns 4,505 shares of the healthcare conglomerate's stock worth $1,872,000 after buying an additional 76 shares during the period. CTC Alternative Strategies Ltd. bought a new position in UnitedHealth Group in the 2nd quarter worth $316,000. Oarsman Capital Inc. boosted its holdings in UnitedHealth Group by 1.0% during the second quarter. Oarsman Capital Inc. now owns 4,497 shares of the healthcare conglomerate's stock valued at $1,869,000 after acquiring an additional 45 shares during the period. Finally, Rothschild Capital Partners LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $998,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Royal Bank Of Canada raised their target price on UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a report on Friday, July 17th. TD Cowen increased their price objective on UnitedHealth Group from $337.00 to $430.00 and gave the company a "hold" rating in a research report on Tuesday, July 14th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an "overweight" rating in a research note on Tuesday, July 21st. Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. Finally, Zacks Research raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 13th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $456.56.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $389.92 on Tuesday. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $412.95 and a 200 day simple moving average of $361.54. The firm has a market capitalization of $349.99 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the previous year, the firm posted $4.08 EPS. The business's revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is currently 59.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source